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ABSTRACT
Tumor derived exosomes are vesicles which contain proteins and microRNAs 
that mediate cell-cell communication and are involved in angiogenesis and tumor 
progression. Curcumin derived from the plant Curcuma longa, shows anticancer 
effects. Exosomes released by CML cells treated with Curcumin contain a high amount 
of miR-21 that is shuttled into the endothelial cells in a biologically active form. 
The treatment of HUVECs with CML Curcu-exosomes reduced RhoB expression and 
negatively modulated endothelial cells motility. We showed that the addition of CML 
control exosomes to HUVECs caused an increase in IL8 and VCAM1 levels, but Curcu-
exosomes reversed these effects thus attenuating their angiogenic properties. This 
DQWLDQJLRJHQLFHIIHFWZDVFRQ¿UPHGZLWKLQin vitro and in vivo vascular network 
IRUPDWLRQ DVVD\V 6:$7+ DQDO\VLV RI WKH SURWHRPLF SUR¿OH RI &XUFXH[RVRPHV
revealed that Curcumin treatment deeply changes their molecular properties, in 
particular, Curcumin induces a release of exosomes depleted in pro-angiogenic 
proteins and enriched in proteins endowed with anti-angiogenic activity. Among 
the proteins differential expressed we focused on MARCKS, since it was the most 
modulated protein and a target of miR-21. Taken together our data indicated that 
also Curcumin attenuates the exosome’s ability to promote the angiogenic phenotype 
and to modulate the endothelial barrier organization. 
INTRODUCTION
Curcumin is a natural polyphenol derived from 
the rhizome of the Curcuma longa endowed with anti-
LQÀDPPDWRU\DQWLR[LGDWLYHDQGDQWLQHRSODVWLFSURSHUWLHV
Curcumin is known to inhibit multiple oncogene-driven 





UHJXODWRU\ 51$V WKDW PRGXODWH JHQH H[SUHVVLRQ E\
WDUJHWLQJWKHƍXQWUDQVODWHGUHJLRQRIP51$>@
,Q OHXNHPLF FDQFHU FHOOV &XUFXPLQ LQGXFHV FHOO
death by apoptosis and inhibits cancer cell proliferation 
E\XSUHJXODWLQJWKHH[SUHVVLRQRIPL5DDQGPL5
UHVXOWLQJLQWKHGHFUHDVHGH[SUHVVLRQRIWKHDQWLDSRSWRWLF
%FODQG LQ WKHGRZQUHJXODWLRQRI:7 DQRQFRJHQH
LQYROYHGLQOHXNHPRJHQHVLV>@5HFHQWO\ZHGHPRQVWUDWHG
that Curcumin treatment of Chronic myelogenous leukemia 









UHGXFHG WKH DQJLRJHQLF FDSDFLW\ RI +89(&V >@ E\
GLUHFWO\WDUJHWLQJ5KR%D5KR*73DVHLGHQWLFDOWR
5KR$ WKDW LV LQYROYHG LQ WKH UHJXODWLRQRIFHOOJURZWK
FHOOXODU VLJQDOLQJ DQG F\WRVNHOHWRQ UHRUJDQL]DWLRQ >@
,Q SDUWLFXODU HQGRWKHOLDO FHOOFHOO MXQFWLRQV PDLQWDLQ D
restrictive barrier that is tightly regulated to allow dynamic 




,Q WKLV ZRUN ZH VKRZHG WKDW H[RVRPHV UHOHDVHG
E\&0/FHOOVWUHDWHGZLWK&XUFXPLQ&XUFXH[RVRPHV
FRQWDLQ D ODUJH DPRXQW RI PL5 ZKLFK DIWHU LWV
GHOLYHU\ LQ +89(&V LV DEOH WR GRZQUHJXODWH 5KR%
7KXV WKHUHVXOWLQJGRZQUHJXODWLRQ LVDEOH WRDIIHFW WKH
endothelium monolayer integrity by modulation of tight 
MXQFWLRQV =2 DQG DGKHUHQW MXQFWLRQ 9(FDGKHULQ
SURWHLQV ,Q RUGHU WR DFKLHYH D ZLGHU FRPSUHKHQVLRQ
RQ WKH PROHFXODU PHFKDQLVPV PHGLDWHG E\ H[RVRPHV
XQGHUO\LQJ WKH PRGXODWLRQ RI DQJLRJHQHVLV ZH DOVR
SHUIRUPHG D SURWHRPLF SUR¿OH RI H[RVRPHV XVLQJ D
6:$7+06DSSURDFK3URWHRPLFDQDO\VHVRIH[RVRPHV
UHOHDVHGE\.FHOOVWUHDWHGZLWK&XUFXPLQFRPSDUHG
ZLWK H[RVRPHV UHOHDVHG E\ FRQWURO FHOOV UHYHDOHG WKDW
&XUFXH[RVRPHVDUHGHSOHWHGLQVHYHUDOSURWHLQVLQYROYHG
LQPLJUDWLRQ DQG DQJLRJHQHVLVZKLOH HQULFKHG LQ DQWL
DQJLRJHQLFSURWHLQV
$PRQJWKHSURWHLQVZKLFKDUHPRGXODWHGLQ&XUFX
H[RVRPHV LQ FRPSDULVRQ ZLWK FRQWURO H[RVRPHV ZH
IRFXVHGRXUDWWHQWLRQRQ0$5&.6P\ULVWR\ODWHGDODQLQH




UHYHUWHG WKH DQJLRJHQLF HIIHFW RI H[RVRPHV UHOHDVHG E\





([RVRPHV UHOHDVHG E\. DQG /$0$ FHOOV
WUHDWHGRUQRWZLWK&XUFXPLQDQG0GXULQJ











([RVRPHV UHOHDVHG E\&0/FHOOV DIWHU WUHDWPHQW
IRU  KRXUV ZLWK  M of Curcumin contain small 


















H[RVRPHV:H REWDLQHG VLPLODU UHVXOWV DIWHU WUHDWPHQW
RI (& ZLWK &XUFXH[RVRPHV UHOHDVHG E\ /$0$
FHOOV WUHDWHG RU QRW ZLWK &XUFXPLQ )LJXUH 6$ 7KH





:H UHFHQWO\ GHPRQVWUDWHG WKDW WKH WUHDWPHQW RI
&0/FHOOVZLWK&XUFXPLQFDXVHVDQLQFUHDVHRIPL5




PL5 LQ+89(&V$V VKRZQ LQ )LJXUH $PL5
OHYHOVLQFUHDVHGLQ+89(&VWUHDWHGZLWK&XUFXH[RVRPHV
FRPSDUHG ZLWK XQWUHDWHG RU FRQWURO H[RVRPHVWUHDWHG
+89(&V
,Q +89(&V WUDQVIHFWHG ZLWK PL5 LQKLELWRU
ƍ20HPL5 ZH REVHUYHG D GHFUHDVH RI PL5
H[SUHVVLRQ EXW WKH WUHDWPHQW ZLWK &XUFXH[RVRPHV
UHYHUWHGWKLVHIIHFW
2Q WKH FRQWUDU\ ZH REVHUYHG WKDW WKH LQFUHDVHG
OHYHO RI PL5 LQ +89(&V WUDQVIHFWHG ZLWK PL5
mimic was further augmented after addition of Curcu-
H[RVRPHV)LJXUH$,QRUGHUWRH[FOXGHWKHSRVVLELOLW\






















ZH IRXQG QR VWDWLVWLFDOO\ VLJQL¿FDQW GLIIHUHQFH RI SUH
PL5H[SUHVVLRQOHYHODIWHUWUHDWPHQWRI(&ZLWKDQG
ȝJPORI.&XUFXH[RVRPHV:HREWDLQHGVLPLODU


















RI PL5 LQKLELWRU LQWR +89(&V FRQWDLQLQJ 5KR%
S(=; LQFUHDVHG WKH DFWLYLW\ RI ¿UHÀ\ OXFLIHUDVH ZLWK


















RI 5KR% P51$ H[SUHVVLRQ $V VKRZQ LQ )LJXUH $
.&XUFXH[RVRPHVFDXVHGDGHFUHDVHRI5KR%P51$
H[SUHVVLRQ,Q+89(&VWUDQVIHFWHGZLWKPL5LQKLELWRU
ƍ20HPL5 5KR%P51$ H[SUHVVLRQ VKRZHG D
 IROG LQFUHDVH FRPSDUHG ZLWK XQWUDVIHFWHG FHOOV 7KH
WUHDWPHQWZLWK&XUFXH[RVRPHVRI+89(&VWUDQVIHFWHG
ZLWKPL5LQKLELWRUFRXQWHUDFWHGWKHHIIHFWRIPL5
LQKLELWRU GHFUHDVLQJ WKH H[SUHVVLRQ RI 5KR% P51$
)LJXUH $ )RUFHG H[SUHVVLRQ RIPL5 LQ+89(&V
GHFUHDVHG WKHUHODWLYHDPRXQWRI5KR%P51$RIDERXW
 )LJXUH $ 7KH DGGLWLRQ RI &XUFXH[RVRPHV LQ
+89(&V WUDQVIHFWHG ZLWK PL5 PLPLF UHLQIRUFHG
WKHGRZQUHJXODWLRQRI5KR%H[SUHVVLRQ)LJXUH$:H
REWDLQHG VLPLODU HIIHFWV LQ +89(&V WUDQVIHFWHG ZLWK
PL5PLPLFDQG LQKLELWRUDQG WUHDWHGZLWKH[RVRPHV
UHOHDVHG E\ /$0$ FHOOV WUHDWHG ZLWK &XUFXPLQ
)LJXUH6'







LQGXFHV DQ H[RVRPHPHGLDWHG LQFUHDVH RIPL5 WKDW










WKDW WKH WUHDWPHQW ZLWK &0/ H[RVRPHV LQFUHDVHG WKH
PRWLOLW\RI(&DVSUHYLRXVO\GHVFULEHG>@
&XUFXH[RVRPHV WUHDWPHQW LQKLELWHG LQ D GRVH




&RQYHUVHO\ WKH WUDQVIHFWLRQ RI PL5 LQKLELWRU LQ (&
LQGXFHVDQLQFUHDVHLQFHOOPRWLOLW\7KHHIIHFWVREVHUYHG
ZLWK WKH WUDQVIHFWLRQZLWKPL5PLPLFDUHHYHQPRUH










7XPRU DQJLRJHQHVLV LV FDXVHG E\ WKH DEHUUDQW
production of angiogenic factors secreted by malignant 
WXPRUFHOOVKRVWFHOOVRUERWK>@,/KDVEHHQVKRZQ
WR UHJXODWHSDWKRORJLFDODQJLRJHQHVLVDVZHOODV WXPRU
JURZWK DQG PHWDVWDVLV $V SUHYLRXVO\ GHPRQVWUDWHG
&0/ H[RVRPHV DGGHG WR +89(&V LQFUHDVHG ,/
P51$OHYHODQGWKLVHIIHFWZDVUHYHUWHGDIWHUWUHDWPHQW
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RI (& ZLWK &XUFXH[RVRPHV )LJXUH $ 7KHVH GDWD
ZHUHFRQ¿UPHGDWSURWHLQ OHYHOE\DQ(/,6$DVVD\RQ
FRQGLWLRQHG PHGLXP RI +89(&V WUHDWHG ZLWK  DQG 
 ȝJPO &XUFXH[RVRPHV DQG FRQWURO H[RVRPHV $V
VKRZQLQ)LJXUH%WKHDGGLWLRQRIH[RVRPHVFDXVHGD
GRVHGHSHQGHQWLQFUHDVHRI,/UHOHDVHGIURP+89(&V
this effect was reverted after treatment with Curcu-
H[RVRPHV:HREWDLQHGVLPLODUUHVXOWVLQ+89(&VWUHDWHG
ZLWK&XUFXH[RVRPHVUHOHDVHGE\/$0$FHOOVERWKDW




. DQG /$0$H[RVRPHV LQGXFHG 9&$0
H[SUHVVLRQDIWHUWUHDWPHQWRIHQGRWKHOLDOFHOOVIRUKRXUV
>@$V VKRZQ LQ)LJXUH& WKHDGGLWLRQRI LQFUHDVLQJ
GRVHV RI H[RVRPHV UHOHDVHG E\ &0/ FHOOV WR+89(&V
FDXVHG D GRVHGHSHQGHQW LQFUHDVH LQ 9&$0 P51$
H[SUHVVLRQ,QHQGRWKHOLDOFHOOVWKHWUHDWPHQWZLWK&XUFX
H[RVRPHV UHYHUWHG WKLV HIIHFW %\ )$&6 DQDO\VLV ZH





SRVLWLYH (& DIWHU WUHDWPHQW ZLWK &XUFXH[RVRPHV DQG
FRQWURO:HREWDLQHG VLPLODU UHVXOWV LQ+89(&V WUHDWHG
ZLWK &XUFXH[RVRPHV UHOHDVHG E\ /$0$ FHOOV ERWK
DWP51$6XSSOHPHQWDU\)LJXUH6$DQGSURWHLQOHYHO
6XSSOHPHQWDU\)LJXUH6%DQG6&
&XUFXH[RVRPHVLQKLELWHGin vitroDQGin vivo 
WXEHIRUPDWLRQ
:H DQDO\]HG WKH DELOLW\ RI +89(&V WR IRUP
capillary-like structures when plated on Matrigel as an 
in vitroPRGHORIDQJLRJHQHVLV+89(&VPDLQWDLQHGLQ
low serum medium were unable to form a tube network 














7KH DQJLRJHQLF SRWHQWLDO RI&0/ H[RVRPHVZDV
then assayed in vivo E\ H[DPLQLQJ WKH UHFUXLWPHQW RI




observation is supported by the decreased haemoglobin 
FRQFHQWUDWLRQLQWKH&XUFXH[RVRPHVFRQWDLQLQJ0DWULJHO
SOXJV ZLWK UHVSHFW WR FRQWURO H[RVRPHVFRQWDLQLQJ
0DWULJHOSOXJV)LJXUH&:HREWDLQHGVLPLODUUHVXOWV






















,QWHUHVWLQJO\+89(&V FHOOV WUHDWHGZLWK FRQWURO
.H[RVRPHVVKRZHGDQLQFUHDVHLQ9(*)5P51$
H[SUHVVLRQOHYHOVFRPSDUHGWRWKHWUHDWPHQWZLWK&XUFX






MXQFWLRQV ZH DQDO\]HG E\ LPPXQRÀXRUHVFHQFH WKH
ORFDOL]DWLRQRI=2LQFRQWURO(&DQG&XUFXH[RVRPHV
WUHDWHG FHOOV ,Q +89(&V WKH DGGLWLRQ RI  JPO
RI FRQWURO H[RVRPHV FDXVHG D GHORFDOL]DWLRQ RI =2
FRPSDUHGWR+89(&VFRQWUROLQZKLFK=2ZDVORFDOL]HG
LQ SODVPDPHPEUDQH ,Q+89(&V WUHDWHGZLWKJ
PO RI &XUFXH[RVRPHV UHOHDVHG E\ . )LJXUH $
DQG /$0$ 6XSSOHPHQWDU\ )LJXUH 6$ FHOOV D
ORFDOL]DWLRQRI=2LQ+89(&VSODVPDPHPEUDQHVLPLODU
WRFRQWUROFHOOVZDVREVHUYHG
:H DOVR GHWHUPLQHG WKH HIIHFWV RI H[RVRPHV RQ
WKH H[SUHVVLRQRI9(&DGKHULQ DQ HQGRWKHOLDO VSHFL¿F
WUDQVPHPEUDQH DGKHVLRQ PROHFXOH &RQWURO FHOOV KDG




FRQWURO FHOOV ,QWHUHVWLQJO\ WKLV GHVWDELOL]LQJ HIIHFWZDV




Vascular permeability is a parameter of endothelial 
cell function and its alterations are a feature of different 
SURFHVVHV LQFOXGLQJ FDQFHU PHWDVWDVLV ,Q RUGHU WR
)LJXUH7UHDWPHQWRI+89(&VZLWK&XUFX([RVRPHVPRGXODWHG ,/DQG9&$0H[SUHVVLRQ (A5HDO WLPH3&5
DQDO\VLV VKRZHG WKDW ,/P51$H[SUHVVLRQGHFUHDVHG LQGRVHGHSHQGHQWPDQQHU LQ(& WUHDWHG&XUFXH[RVRPHVFRPSDUHG WRFRQWURO
H[RVRPHV9DOXHV)2,IROGRILQGXFWLRQDUHWKHPHDQ6'RILQGHSHQGHQWH[SHULPHQWVppB(/,6$DVVD\VKRZHG













WKH WUHDWPHQW ZLWK &XUFXH[RVRPHV SDUWLDOO\ SURWHFWHG








PRQROD\HU ZDV DOWHUHG &RQYHUVHO\ WKH WUHDWPHQW RI





WKH HQGRWKHOLDO PRQROD\HU FDXVHG D GHFUHDVH RI 5KR%
H[SUHVVLRQFRPSDUHGWRWKHWUHDWPHQWZLWK.FRQWURO
H[RVRPHV ([R .  JPO 7KHVH REVHUYDWLRQV




7XPRU FHOOGHULYHG H[RVRPHV FDQPRGXODWH WDUJHW
FHOOV SKHQRW\SH WKURXJK WKH GHOLYHU RI ERWK 51$V DQG
FDUJRSURWHLQV7REHWWHULQYHVWLJDWHKRZH[RVRPHSURWHLQV
IURP FXUFXPLQWUHDWHG. FHOOV FDQPHGLDWH WKH DQWL
DQJLRJHQLF HIIHFW REVHUYHG RQ +89(&V D SURWHRPLF
DQDO\VLV XVLQJ D 6:$7+06 DSSURDFK ZDV SHUIRUPHG
(for Materials and Methods see online Supplementary 











,QGHSHQGHQW $FTXLVLWLRQ ',$ PHWKRG ZLWK D WDUJHWHG
GDWDH[WUDFWLRQVWUDWHJ\2QO\SURWHLQVZLWKD pDQG
DORJIROGFKDQJH!RUíIRUXSUHJXODWHGDQG
downregulated proteins respectively) were considered 
IRU IXUWKHU DQDO\VLV$ WRWDO RI  SURWHLQV GLIIHUHQWLDOO\
UHJXODWHG LQ H[RVRPHV UHOHDVHG E\. FHOOV IROORZLQJ
WUHDWPHQWZLWKFXUFXPLQZHUHLGHQWL¿HGLQFRPSDULVRQZLWK
H[RVRPHVVHFUHWHGE\.FRQWUROFHOOV&XUFXH[RVRPHV
VKRZHG  XSUHJXODWHG DQG  GRZQUHJXODWHG SURWHLQV
6XSSOHPHQWDU\ 7DEOHV 6 DQG 6 $ *2 HQULFKPHQW
DQDO\VLV RQ DOO GLIIHUHQWLDOO\ H[SUHVVHG SURWHLQV ZDV
SHUIRUPHGXVLQJ L3DWKZD\*XLGHKWWSZZZDGYDLWDELR
FRPLSDWKZD\JXLGHKWPO KLJKOLJKWLQJ D VLJQL¿FDQW
HQULFKPHQW IRU WKRVH*2 WHUPV OLQNHGZLWK ELRV\QWKHWLF
SURFHVVHVDQGWUDQVODWLRQ,QSDUWLFXODUWKHIROORZLQJ*2
WHUPVUHVXOWHGVLJQL¿FDQWO\HQULFKHGLQWUDFHOOXODUWUDQVSRUW
(pYDOXH %3 WUDQVODWLRQpYDOXH %3
cellular biosynthetic process (pYDOXH %3QXFOHLF
acid binding (pYDOXH 0)DQLRQWUDQVPHPEUDQH
transporter activity (pYDOXH    0) QLWULFR[LGH
synthase regulator activity (pYDOXH    0)



















ZH IRFXVHG RXU DWWHQWLRQ RQ 0$5&.6UHODWHG SURWHLQ
0$5&.6/ EHFDXVH LW LV WKH PDLQO\ GRZQUHJXODWHG
SURWHLQ ZLWK D IROG GRZQUHJXODWLRQ ,QWHUHVWLQJO\
PL5KDVEHHQVKRZQWRVSHFL¿FDOO\ WDUJHW WKHP51$
RI0$5&.6 6R ZH GHFLGHG WR IXUWKHU LQYHVWLJDWH WKH




5HFHQWO\ PL5 KDV EHHQ VKRZQ WR GLUHFWO\
WDUJHW0$5&.6 ELQGLQJ LQ WKH ƍ XQWUDQVODWHG UHJLRQ
IURP WKH QW±RI ƍ875P51$0$5&.6DUH
known to affect the architecture of the actin cytoskeleton 
LQ HQGRWKHOLDO FHOOV PRGXODWLQJ (& PRWLOLW\ DQG
SHUPHDELOLW\>@,QRUGHUWRFRQ¿UPWKHGDWDZKLFKKDYH





H[SUHVVLRQ 0RUHRYHU &XUFX([RVRPHV WUHDWPHQW RI






$W SURWHLQ OHYHO ZH REVHUYHG DQ LQFUHDVH RI
0$5&.6 LQ +89(&V WUHDWHG ZLWK FRQWURO H[RVRPHV
FRPSDUHG WR XQWUHDWHG +89(&V ZKLOH WKH WUHDWPHQW
ZLWK&XUFXH[RVRPHVUHYHUWHGWKLVHIIHFW)LJXUH&:H
DOVRREVHUYHGE\)$&6DQDO\VHVDGHFUHDVHRI0$5&.6






H[RVRPHVKDVSURYHG WREHDEOH WR UHYHUW WKHHIIHFWRQ







2XU UHVHDUFK JURXS GLVFRYHUHG WKDW &0/ FHOOV DIIHFW
vascular remodeling in in vitro and in vivo models 
WKURXJKWKH,/PRGXODWLRQLQHQGRWKHOLDOFHOOV:HDOVR
GHPRQVWUDWHG WKDW H[RVRPHV UHOHDVHG IURP &0/ FHOOV
VWLPXODWHERQHPDUURZVWURPDOFHOOVWRSURGXFH,/WKDW
LQWXUQLVDEOHWRDIIHFWERWKin vitro and in vivo leukemia 
FHOOPDOLJQDQWSKHQRW\SH>@
5HFHQWO\ WKH FULWLFDO UROH SOD\HG E\ PL51$
GHOLYHUHGE\H[RVRPHV LQ WKH W\SLFDO FHOOWRHQGRWKHOLDO
FHOOFRPPXQLFDWLRQLQOHXNHPLDKDVEHHQLQYHVWLJDWHG,Q
RXUSUHYLRXVSDSHUZHGHPRQVWUDWHGWKDWPL5VKXWWOHG
E\ &0/ H[RVRPHV LV ELRORJLFDOO\ DFWLYH LQ WDUJHWLQJ
endothelial cells and affects CML cell motility and adhesion 
>@8PH]XHWDOREVHUYHGWKDWH[RVRPHVFROOHFWHGIURP
PL5DRYHUH[SUHVVLQJ OHXNHPLD FHOOV HQWHUHG LQWR
HQGRWKHOLDOFHOOVUHVXOWLQJLQDQHQKDQFHGPLJUDWLRQDQG
WXEHIRUPDWLRQ>@7KHVHGDWDLQGLFDWHGWKDWH[RVRPDO






LQ WXUPHULF KDV EHHQ UHFRJQL]HG DV D SURPLVLQJ DQWL
cancer drug and is being developed as a chemopreventive 
DJHQWLQYDULRXVFDQFHUV3UHFOLQLFDOVWXGLHVKDYHVKRZQ
WKDW &XUFXPLQ KDV DQWLR[LGDQW DQWLLQÀDPPDWRU\ DQG
DQWLSUROLIHUDWLYH DFWLYLWLHV &XUFXPLQ DIIHFWV VHYHUDO




>@ 7KH HIIHFWV RI &XUFXPLQ RQPL51$V H[SUHVVLRQ
ZDV LQLWLDOO\ VWXGLHG LQ SDQFUHDWLF FDQFHU FHOOV >@
&XUFXPLQZDVUHSRUWHGWRGRZQUHJXODWHWKHH[SUHVVLRQ
RI  PL51$V LQFOXGLQJ PL5D NQRZQ WR WDUJHW
0(7SURWRRQFRJHQHDQGWKHGRZQVWUHDPH[WUDFHOOXODU
VLJQDOUHJXODWHG NLQDVH  >@ ,W ZDV DOVR GHVFULEHG





:H GHPRQVWUDWHG WKDW &XUFXPLQ FDXVHG D GHFUHDVH
RI FHOOXODUPL5 LQ&0/ FHOOVZKLOH LQFUHDVHGPL5
VHOHFWLYHSDFNDJLQJLQH[RVRPHV)XUWKHUPRUHZHVKRZHGWKDW





VHYHUDO IXQFWLRQV RI HQGRWKHOLDO FHOOV LQFOXGLQJPLJUDWLRQ
>@ DQG DQJLRJHQHVLV >@ ,WZDV GHPRQVWUDWHG WKDWPL5




,Q WKLV VWXG\ZH VKRZHG WKDW H[RVRPHV UHOHDVHG
by CML cells after Curcumin treatment deeply changed 





2XU GDWD DUH LQ DJUHHPHQW ZLWK WKH UHVXOWV RI
6DEDWHOHWDOGHPRQVWUDWLQJWKDWPL5RYHUH[SUHVVLRQ
UHGXFHVWKHDQJLRJHQLFFDSDFLW\RI+89(&V>@WDUJHWLQJ




cell membranes by changing the membrane-associated 
F\WRVNHOHWDO DFWLQ (QGRWKHOLDO 5KR SURWHLQV DUH DOVR
LQYROYHGLQ,&$0PHGLDWHGVLJQDOLQJHYHQWV>@5KR








Several studies have also shown that Curcumin is 
DEOHWRFRXQWHUDFWWKHVWLPXOLLQGXFHGSURGXFWLRQRI,/
WKURXJK WKHPRGXODWLRQRI1)±ț% -1.(5. DQG
S SDWKZD\V:DQJ HW DO VKRZHG WKDW &XUFXPLQ KDG
DQ LQKLELWRU\ HIIHFW RQ WKH H[SUHVVLRQ RI ,/ LQGXFHG
E\'(+3>@:HREVHUYHGWKDW&0/H[RVRPHVDGGHG























GHPRQVWUDWHG WKDW &XUFXPLQ KDG D EHQH¿FLDO HIIHFW RQ








FRQWURO +89(&V LQ ZKLFK =2 DQG9(&DGKHULQ ZDV
ORFDOL]HG LQ SODVPD PHPEUDQH 7KLV HIIHFW UHYHUWHG LQ
+89(&VWUHDWHGZLWK&0/&XUFXH[RVRPHV
,QWHUHVWLQJO\ RXU 6:$7+ DQDO\VLV RI H[RVRPHV
released by control and Curcumin treated cells evidenced 
DUHOHYDQWDQGVLJQL¿FDQWPRGXODWLRQRIVHYHUDOSURWHLQV
LQYROYHG LQ WKH DQJLRJHQLF SURFHVV ,Q SDUWLFXODU
proteomic data highlighted that Curcumin induced the 
UHOHDVHRIH[RVRPHVGHSOHWHGLQSURDQJLRJHQLFSURWHLQV
VXFK DV ,QWHUIHURQLQGXFHG WUDQVPHPEUDQH SURWHLQ 
,),70DFWLQLQEDVLJLQ*XDQLQHQXFOHRWLGHELQGLQJ
SURWHLQVXEXQLWEHWDOLNH*1%/DQG0$5&.6
>@ DQG HQULFKHG LQ SURWHLQV VXFK DV 3OHFNVWULQ >@
DQG0LGNLQH>@ZKLFKSUHVHQWNQRZQDQWLDQJLRJHQLF
DELOLWLHV7DEOH:HIRFXVHGRXUDWWHQWLRQRQ0$5&.6
since it was the most modulated protein and also a target 
RIPL50$5&.6LVDSKRVSKRSURWHLQWKDWEHORQJV
to the myristoylated alanine-rich C-kinase substrate 
0$5&.6IDPLO\DQGSRVVHVVHVDFWLQELQGLQJSURSHUWLHV
through which it is implicated in control of cell motility 
>@0$5&.6G\VUHJXODWLRQLVFORVHO\DVVRFLDWHGZLWK
metastasis in a wide range of cancers and it is also an 
LQGLFDWRURISRRUSURJQRVLV
)LJXUH&XUFXPLQPRGXODWHV0$5&.6H[SUHVVLRQ LQ.FHOOVDQG+89(&V (A5HDO WLPH3&5DQDO\VLV VKRZHG
WKDW LQ . FHOOV0$5&.6P51$ H[SUHVVLRQ GHFUHDVHV DIWHU WUHDWPHQW ZLWK &XUFXPLQ UHVSHFW WR XQWUHDWHG FHOOV 5HDO WLPH 3&5



























cells and VSMCs) through several molecular 
PHFKDQLVPVSURWHLQNLQDVH%SDWKZD\GLUHFW
ELQGLQJWRDFWLQFRQWURORI3,3DYDLODELOLW\DW
the plasma membrane and regulation of the small 
*73DVHV5DFDQG&GF.H\PHGLDWRURIWKH















endothelial lumen formation by regulating tight 
MXQFWLRQDVVHPEO\
>±@








































this protein was shown to contribute to maintain the vascular 
LQWHJULW\E\VWDELOL]LQJWKHHQGRWKHOLDOMXQFWLRQV
2YHUDOO WKHVH REVHUYDWLRQV GHPRQVWUDWHG WKDW
&XUFXPLQ LQGXFHG D PRGL¿FDWLRQ RI &0/ H[RVRPHV
FRPSRVLWLRQ DW SURWHLQ DQG PLFUR51$ OHYHO &XUFX
H[RVRPHVZHUHDEOHWRPRGXODWHWKHHQGRWKHOLDOEDUULHU
RUJDQL]DWLRQ DQG DWWHQXDWHG WKH DQJLRJHQLF SKHQRW\SH





+89(&V ZHUH REWDLQHG IURP /RQ]D &ORQHWLFV
9HUYLHUV %HOJLXP DQG JURZQ LQ HQGRWKHOLDO JURZWK








Massive up-regulation in vascular endothelial 








3 )HUULWLQOLJKWFKDLQ)7/ ± 
%LQGLQJWRDDDVXEGRPDLQRI+NDVR































3 3OHFNVWULQ3/(.  
,WVRYHUH[SUHVVLRQLQ&26FHOOVOHDGVWRD






transmembrane cadherins to the intracellular 
PLFURWXEXOHQHWZRUNRISURWHLQV
>@
(33- Midkine (MDK)  
$EURJDWLRQRIWKH9(*)$±LQGXFHGSUROLIHUDWLRQ
of human microvascular endothelial cells in vitro 
through the downregulation of proangiogenic 
cytokines and through the upregulation of 
DQWLDQJLRJHQLFIDFWRUV'RZQUHJXODWLRQRI
9(*)$±LQGXFHGQHRYDVFXODUL]DWLRQDQG
vascular permeability in vivo
>@
Oncotarget15www.impactjournals.com/oncotarget







/&$'93 instrument equipped with a binary 
SXPS /&$'93 D 89 63'0$ 'LRGH $UUD\
GHWHFWRUDȝ/ LQMHFWRUDQGDFRPSXWHU LQWHJUDWLQJ
DSSDUDWXV (= 6WDUW  VRIWZDUH +3/& VROYHQWV
+L3HU6ROY&KURPDQRUPZHUH SXUFKDVHG IURP9:5
,QWHUQDWLRQDO0LODQ,WDO\&KURPDWRJUDSKLFVHSDUDWLRQ
was achieved on a reversed-phase column Chromolith® 
3HUIRUPDQFH 53H0HUFN  î  PP DQG D
mobile phase consisted of methanol [Mobile phase 
$@ DQG 7)$  YY DTXHRXV VROXWLRQ >0RELOH
SKDVH %@ 7KH GHYHORSHG JUDGLHQW PHWKRG FRQVLVWHG
RI FKDQJH LQPRELOH SKDVH%ZLWK UHVSHFW WR WLPH
ĺPLQ%ĺPLQ%
ĺPLQ % ĺPLQ %
ĺ PLQ  % 7KH PRELOH SKDVH ZDV
¿OWHUHGWKURXJK:KDWPDQ¿OWHUPm and degassed 
EHIRUH XVH 7KH ÀRZ UDWH ZDV VHW DW  P/PLQ DQG
WKH89ZDYHOHQJWK DW   DQGQP ,Q
WKHVH FRQGLWLRQV WKH UHWHQWLRQ WLPH IRU &XUFXPLQ
ZDV PLQXWHV 3UHSDUDWLRQ RI VWRFN DQGZRUNLQJ
VWDQGDUG VROXWLRQV ZDV SHUIRUPHG DV IROORZ  PJ
RIFXUFXPLQZRUNLQJVWDQGDUGGLVVROYHG LQP/RI
DFHWRQH 7KLV VWRFN VWDQGDUG VROXWLRQ ZDV GLOXWHG WR
SUHSDUHVL[VHWVRIFDOLEUDWLRQVWDQGDUGVRIFXUFXPLQDW
FRQFHQWUDWLRQV UDQJHRI±PJP/ LQ DFHWRQH
/24 PJPO7KH VWDQGDUG FDOLEUDWLRQ FXUYH
was constructed using peak area versus known 
FRQFHQWUDWLRQVRIFXUFXPLQ+3/&UHSRUWVZHUHKLJKO\
reproducible and linearly related to concentration 
UHJUHVVLRQ HTXDWLRQ \    î±  5 
5  7KH OLQHDU UHJUHVVLRQ OLQH ZDV XVHG WR
determine the linearity and concentration of the samples
 PO RI H[RVRPH VDPSOHV  JO LQ SURWHLQ
FRQWHQW GHWHUPLQHG E\ %UDGIRUG PHWKRG LVRODWHG E\
.DQG/$0$FHOOVWUHDWHGRUQRWZLWK&XUFXPLQ





0HWK\OWKLD]ROWHWUD]ROLXP 077 DVVD\ ZDV
H[HFXWHGDVSUHYLRXVO\GHVFULEHG>@+89(&VZHUH
SODWHGLQWULSOLFDWHDWî4 per well and treated with 
&XUFXH[RVRPHV  DQG  JPO IRU  KRXUV




([RVRPHV UHOHDVHG E\ . DQG /$0$
FHOOVWUHDWHGRUQRWZLWK&XUFXPLQDQG0) 
GXULQJ D  KRXUV FXOWXUH SHULRG ZHUH LVRODWHG IURP
WKH FXOWXUH PHGLXP VXSSOHPHQWHG ZLWK  )%6
SUHYLRXVO\XOWUDFHQWULIXJHGE\GLIIHUHQWFHQWULIXJDWLRQV








7RWDO FHOOXODU 51$ ZDV LVRODWHG IURP +89(&V
DQG LQFXEDWHG IRU  KRXUV ZLWK H[RVRPHV UHOHDVHG E\
.DQG/$0$FHOOVWUHDWHGRUQRWZLWKFXUFXPLQ
XVLQJ WKH 51$VSLQ 0LQL *( +HDOWKFDUH 6FLHQFH
8SSVDOD6ZHGHQ)RU5KR%,/9&$0=29(
&DGKHULQ 9(*)5 DQG 0$5&.6 P51$ GHWHFWLRQ
1 J RI WRWDO 51$ ZDV UHYHUVH WUDQVFULEHG XVLQJ WKH
+LJK &DSDFLW\ F'1$$UFKLYH NLW /LIH 7HFKQRORJLHV
&DUOVEDG&DOLIRUQLD86DFFRUGLQJWRPDQXIDFWXUHU¶V
LQVWUXFWLRQV5743&5ZDVSHUIRUPHGLQZHOOSODWHV
XVLQJ WKH 6WHS2QH 5HDO7LPH 3&5 V\VWHP $SSOLHG
%LRV\VWHP )RU TXDQWLWDWLYH 6<%(5®*UHHQ 5HDO
7LPH3&5UHDFWLRQVZHUHFDUULHGRXWLQDWRWDOYROXPH
RI  ȝO FRQWDLQLQJ î 6<%5®*UHHQ , 0DVWHU 0L[
$SSOLHG%LRV\VWHPVȝOF'1$DQGQ0IRUZDUG
DQG UHYHUVH SULPHUV 3ULPHUV VHTXHQFH ZHUH *$3'+
ƍ$7****$$**7*$$**7&*ƍƍ***7&$77*$7 












5HDOWLPH 3&5 ZDV SHUIRUPHG LQ GXSOLFDWH IRU
HDFK GDWD SRLQW 5HODWLYH FKDQJHV LQ JHQH H[SUHVVLRQ
between control and treated samples were determined 
ZLWK WKH ǻǻ&W PHWKRG &KDQJHV LQ WKH WDUJHW P51$
FRQWHQW UHODWLYH WR*$3'+ZHUHGHWHUPLQHGXVLQJ WKH






3&5 6\VWHP 4,$*(1 +LOGHQ *HUPDQ\ 7RWDO
FHOOXODU51$DQGPL51$VZHUHLVRODWHGIURP+89(&V
LQFXEDWHGRUQRWZLWKH[RVRPHVXVLQJWKH51$VSLQ0LQL
*( +HDOWKFDUH 6FLHQFH 8SSVDOD 6ZHGHQ 5HYHUVH





TXDQWL¿FDWLRQ RI SUHFXUVRU PL51$ 4XDQWLWDWLYH 5HDO
7LPH3&5ZDVSHUIRUPHGXVLQJPL6FULSW6<%5*UHHQ
3&5.LW4,$*(1+LOGHQ*HUPDQ\0DWXUHPL5
ZDV GHWHFWHG E\PL6FULSW 3ULPHU$VVD\ DQG SUHFXUVRU
PL5 E\ PL6FULSW 3UHFXUVRU $VVD\V DFFRUGLQJ WR
PDQXIDFWXUHU¶V LQVWUXFWLRQV 518 ZDV XVHG DV
HQGRJHQRXVFRQWURO([SUHVVLRQ OHYHOVRIPL51$VDQG
SUHPL51$ZHUHGHWHUPLQHGXVLQJ WKHFRPSDUDWLYH&W





7UDQVIHFWLRQ RI PL6FULSW PL5 LQKLELWRU






PL5PLPLF0) were diluted in 100 ȝl of culture 





4,$*(1 +LOGHQ *HUPDQ\ DQG $OO6WDUV 1HJDWLYH
&RQWURO VL51$ 0LPLF 1HJDWLYH &RQWURO 4,$*(1
+LOGHQ *HUPDQ\ ZHUH XVHG DV QHJDWLYH FRQWUROV DV










¿UHÀ\OXFLIHUDVHUHSRUWGLOXWHGLQȝO culture medium 
ZLWKRXWVHUXP+89(&VZHUHFRWUDQVIHFWHGZLWKSPRO
RIPL5PLPLFRUPL5 LQKLELWRUXVLQJ$WWUDFWHQH
7UDQVIHFWLRQ 5HDJHQW 4,$*(1 +LOGHQ *HUPDQ\
DFFRUGLQJWRPDQXIDFWXUHU¶VSURWRFRO
7RWHVWLIH[RVRPDOPL5WDUJHWV5KR%P51$
+89(&V ZHUH LQFXEDWHG ZLWK  ȝJPO RI H[RVRPHV
UHOHDVHG E\ &0/ FHOOV WUHDWHG RU QRW ZLWK &XUFXPLQ
DIWHU WKH WUDQVIHFWLRQ ZLWK S(=;07YHFWRU )LUHÀ\
DQG 5HQLOOD /XFLIHUDVH DFWLYLWLHV ZHUH PHDVXUHG
FRQVHFXWLYHO\XVLQJWKHNLW'XDO*OR®/XFLIHUDVH$VVD\
6\VWHP3URPHJD&RUS0DGLVRQ:,86$KRXUV








CM aliquots were then centrifuged to remove cellular 
GHEULV DQG ,/ SURWHLQ OHYHOVZHUHPHDVXUHG XVLQJ DQ




H[RVRPHV ZHUH VXVSHQGHG LQ VHUXPIUHH 530, 
PHGLXPVXSSOHPHQWHGZLWK%6$LQWUDQVZHOOVZLWK
ȝPSRUH¿OWHUVDQGH[SRVHG WRFRPSOHWH530,
DV FKHPRDWWUDFWDQW IRU  KRXUV$IWHU LQFXEDWLRQ FHOOV
PLJUDWHGLQWKHERWWRPZHOOVZHUHFRXQWHG
3HUPHDELOLW\DVVD\











on the in vitro vascular tube formation as previously 
GHVFULEHG>@([RVRPHVUHOHDVHGE\.DQG/$0$
FHOOVWUHDWHGRUQRWZLWK&XUFXPLQ0ZHUHDGGHG
WR +89(&V SODWHG RQ 0DWULJHO LQ HQGRWKHOLDO EDVDO
PHGLXPFRQWDLQLQJRI)%6DVLQGLFDWHG&HOOVZHUH




$OO DQLPDO H[SHULPHQWV ZHUH FRQGXFWHG LQ IXOO





100 J . DQG /$0$ FHOOVGHULYHG H[RVRPHV
WUHDWHGRUQRWZLWK&XUFXPLQRU3%6QHJDWLYHFRQWURO
$IWHUZHHNV WKHSOXJVZHUHFROOHFWHGDQG WKHGHJUHH




+89(& PRQROD\HUV ZHUH JURZQ WR FRQÀXHQFH
RQFRYHUVOLSVFRDWHGZLWKW\SH,FROODJHQ&DOELRFKHP
'DUPVWDGW *HUPDQ\ DQG ZHUH WUHDWHG ZLWK  ȝJ











. DQG /$0$ H[RVRPHV ZHUH ODEHOHG ZLWK
3.+ DFFRUGLQJ WR VXSSOLHU¶V LQIRUPDWLRQ %ULHÀ\
H[RVRPHVFROOHFWHGDIWHUWKHîJXOWUDFHQWULIXJDWLRQ
ZHUH LQFXEDWHG ZLWK 3.+ IRU  PLQ DW URRP
WHPSHUDWXUH/DEHOHGH[RVRPHVZHUHZDVKHG LQ3%6E\
XOWUDFHQWULIXJDWLRQ WKH SHOOHWV ZHUH UHVXVSHQGHG LQ ORZ












LQGHSHQGHQWO\ DQG VHTXHQWLDO GHWHFWLRQ ZDV SHUIRUPHG









î  FHOOVZHUHZDVKHG LQ3%6 DQG LQFXEDWHGZLWK
DQWL9&$03( DQWLERG\  ȝO %' %LRVFHQFHV
0RXQWDLQ9LHZ&$86$IRUPLQDW&DFFRUGLQJ
WR PDQXIDFWXUHU¶V UHFRPPHQGDWLRQV ,VRW\SHPDWFKHG
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